Stay updated on Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.

Latest updates to the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page
- Check3 days agoChange DetectedLocations (participating sites) were expanded with new sites in the United States, Argentina, Brazil, China, and India, among others. Some previously listed locations were removed, and a revision note shows the page updated to v3.3.3.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the Study Details page. This appears to be a general site version update with no visible changes to trial content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe government funding operating-status notice/banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedThe changes shown appear to be minor UI/formatting adjustments with no alteration to core study information (title, criteria, interventions, outcomes, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedThe study record now shows 'Results Submitted' instead of 'No Results Posted'.SummaryDifference0.0%

- Check82 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

Stay in the know with updates to Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.